Editors' ChoiceCancer

Everything you splice can and will be used against you

See allHide authors and affiliations

Science Translational Medicine  21 Sep 2016:
Vol. 8, Issue 357, pp. 357ec151
DOI: 10.1126/scitranslmed.aah7025

Article Information

vol. 8 no. 357 357ec151

DOI: 
https://doi.org/10.1126/scitranslmed.aah7025
Published By: 
American Association for the Advancement of Science
Print ISSN: 
1946-6234
Online ISSN: 
1946-6242
History: 
  • .
Copyright & Usage: 
Copyright © 2016, American Association for the Advancement of Science

Author Information

  1. Saar Gill
  1. Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Email: saar.gill{at}uphs.upenn.edu

Altmetric

Article usage

Article usage: September 2016 to September 2019

AbstractFullPdf
Sep 201603630
Oct 20160510
Nov 2016092
Dec 2016080
Jan 2017090
Feb 20170250
Mar 20170240
Apr 20170440
May 20170220
Jun 20170170
Jul 20170260
Aug 20170290
Sep 20170360
Oct 20170310
Nov 20170360
Dec 20170270
Jan 20180230
Feb 20180220
Mar 20180250
Apr 20180280
May 20180350
Jun 20180360
Jul 20180200
Aug 20180170
Sep 20180150
Oct 20180190
Nov 20180300
Dec 20180180
Jan 20190180
Feb 20190240
Mar 20190230
Apr 20190150
May 20190140
Jun 20190180
Jul 20190160
Aug 20190150
Sep 2019070

View Full Text

Article Tools

  • Email

  • Alerts
  • Citation tools

  • Everything you splice can and will be used against you

    By Saar Gill

    Science Translational Medicine : 357ec151

    Leukemia progenitor cells are characterized by unique splice isoform patterns and are selectively sensitized to spliceosome modulation.

    CiteULike logo Connotea logo del.icio.us logo Digg logo Facebook logo Google logo Mendeley logo Reddit logo Twitter logo

Related Content

Similar Articles in:

Citing Articles in:

Navigate This Article